Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Over 19,000 persons in the Bono Region are living with HIV and AIDS, according to the Bono, Bono East and Ahafo Regional ...
Indian River County recorded the highest rate of new cases on the Treasure Coast, with 14 per 100,000 people diagnosed with ...
Merck said on Wednesday that its experimental oral HIV treatment met the main goal of a late-stage trial. The company said ...
Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...
Prof Nawangwe said Makerere University — ranked second in Africa and 63rd globally — continues to bolster its profile as a ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...
Burlington Free Press on MSN
UVM joins major study on drug use and treatment barriers across New England
The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...
Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...
Cryo-EM revealed HIV-1 integrase’s distinct structures as it shifts between its two roles of DNA integration and RNA-binding.
But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback